Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Navigating The World Of Biopharmaceuticals

Biopharmaceuticals refer to medicinal / therapeutic products that are either manufactured using living organisms or semi-synthesized from biological sources. These are essentially complex biological macromolecules, having high molecular weights, or cell-based products, which are not directly extracted from native biological sources, rather are produced using biotechnology tools and methods. The following figure provides an illustrative

[ Read More ]

Exploring Viral Vectors For Targeted Gene Therapy

Over time, gene therapy has evolved into a promising treatment option for a number of diseases, including cancers, rare inherited disorders and certain infectious diseases. In fact, gene therapies are also being developed for clinical conditions, which currently have no available treatment option. This can be attributed to the fact that gene therapies and genetically

[ Read More ]

The Critical Role of Cold Chain Logistics in Healthcare

Logistics is defined as the process of planning, implementing and controlling a set of processes in order to ensure efficient shipment / storage of products from the source to the point of consumption. Specifically, cold chain logistics refer to the transportation of temperature-sensitive products from the manufacturing site to a desired destination, in a temperature-controlled

[ Read More ]

Biopharmaceutical Contract Manufacturing: The Need of The Hour

Biologics represents one of the fastest growing segments of the pharmaceutical industry. This can be attributed to the rapid pace of innovation in this field, driven by the need for effective and personalized pharmacological interventions. Although biopharmaceuticals offer significant profit margins and have demonstrated the potential to treat a myriad of disease indications, they are

[ Read More ]

Maximizing Medicinal Potential Through Bioavailability Enhancement Technologies

Over the last couple of decades, the concept of bioavailability has garnered significant attention in the pharmaceutical industry. It is considered to be one of the most important pharmacokinetic properties of a drug. Bioavailability refers to the proportion of a drug that reaches systemic circulation unaltered, post dose administration. It is a direct consequence of

[ Read More ]

Revolutionizing Disease Diagnosis Through AI Driven Digital Pathology

Pathology is the science of diagnosing diseases, primarily through collecting and analyzing samples of tissues, cells and body fluids. The traditional process of pathology involves the evaluation of biopsy, wherein tissues are preserved with chemical fixatives (such as formalin) and further transferred to histology labs. Following this, the specimen undergoes a set of processes, such

[ Read More ]

How DNA Encoded Libraries Expedite Drug Discovery

Drug discovery and development is a complex and tedious process requiring a significant amount of time and resources. In fact, on an average, the entire drug development process, from the demonstration of proof-of -concept to commercial launch, takes around 10-15 years and requires huge capital investments (USD 4-10 billion). Moreover, only a small fraction of

[ Read More ]

Exploring The Growing Demand For Digital Therapeutics

Long-term clinical conditions, such as diabetes, obesity, hypertension, mental health problems and sleep disorders, usually impose a significant burden on the overall healthcare system, accounting for approximately USD 3.5 trillion of the annual healthcare cost. This has, in turn, led to an increase in demand for elaborate solutions / services. In order to cater to

[ Read More ]